BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 18339022)

  • 1. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan.
    Ishida T; Maniwa K; Kagioka H; Hirabayashi M; Onaru K; Tomioka H; Hayashi M; Tomii K; Gohma I; Ito Y; Hirai T; Ito I; Mishima M
    Respirology; 2008 Mar; 13(2):240-6. PubMed ID: 18339022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children.
    Chiba N; Kobayashi R; Hasegawa K; Morozumi M; Nakayama E; Tajima T; Iwata S; Ubukata K;
    J Antimicrob Chemother; 2005 Oct; 56(4):756-60. PubMed ID: 16131518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN; Sader HS; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
    Farrell DJ; Jenkins SG
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors.
    Aspa J; Rajas O; Rodríguez de Castro F; Blanquer J; Zalacain R; Fenoll A; de Celis R; Vargas A; Rodríguez Salvanés F; España PP; Rello J; Torres A;
    Clin Infect Dis; 2004 Mar; 38(6):787-98. PubMed ID: 14999620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
    Reechaipichitkul W; Assawasanti K; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program.
    Castanheira M; Gales AC; Mendes RE; Jones RN; Sader HS
    Clin Microbiol Infect; 2004 Jul; 10(7):645-51. PubMed ID: 15214878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents.
    Pottumarthy S; Fritsche TR; Sader HS; Stilwell MG; Jones RN
    Int J Antimicrob Agents; 2005 Apr; 25(4):282-9. PubMed ID: 15784306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options for pneumococcal pneumonia in Turkey.
    Oncu S; Erdem H; Pahsa A
    Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004).
    Farrell DJ; Couturier C; Hryniewicz W
    Int J Antimicrob Agents; 2008 Mar; 31(3):245-9. PubMed ID: 18178388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial resistance patterns in Streptococcus pneumoniae isolated from elderly patients: PROTEKT years 1-5 (1999-2004).
    Cantón R; Unal S; Farrell DJ
    Int J Antimicrob Agents; 2007 Dec; 30(6):546-50. PubMed ID: 17931834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-resistant Streptococcus pneumoniae: the beginning of the end for many antibiotics? Australian Group on Antimicrobial Resistance (AGAR).
    Collignon PJ; Bell JM
    Med J Aust; 1996 Jan; 164(2):64-7. PubMed ID: 8569573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?
    Doern GV; Richter SS; Miller A; Miller N; Rice C; Heilmann K; Beekmann S
    Clin Infect Dis; 2005 Jul; 41(2):139-48. PubMed ID: 15983908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
    Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital.
    Bonofiglio L; Ojeda MI; de Mier C; Vay C; Famiglietti A; Gutkind G; Mollerach M
    Int J Antimicrob Agents; 2005 Mar; 25(3):260-3. PubMed ID: 15737523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia.
    Fogarty C; Torres A; Choudhri S; Haverstock D; Herrington J; Ambler J
    Int J Clin Pract; 2005 Nov; 59(11):1253-9. PubMed ID: 16236076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance in sputum isolates of Streptococcus pneumoniae in chronic obstructive pulmonary disease is related to antibiotic exposure.
    Desai H; Richter S; Doern G; Heilmann K; Dohrn C; Johnson A; Brauer A; Murphy T; Sethi S
    COPD; 2010 Oct; 7(5):337-44. PubMed ID: 20854048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.